Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Candace S Johnson

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
Journal of Traumatic Stress|August 31, 2010
Exposure to traumatic events among treatment-seeking, alcohol-dependent women and men without PTSDCandace S Johnson, Jaimee L Heffner, Thomas J Blom, et al.
Anticancer Research|August 5, 2006
The antitumor efficacy of calcitriol: preclinical studiesCandace S Johnson, Josephia R Muindi, Pamela A Hershberger, et al.
The Prostate|February 11, 2009
Central quadrant procurement of radical prostatectomy specimensCarl Morrison, Richard Cheney, Candace S Johnson, et al.
Anticancer Research|August 5, 2006
Vitamin D compounds: clinical development as cancer therapy and prevention agentsDonald L Trump, Josephia Muindi, Marwan Fakih, et al.
Cancer|April 7, 2006
Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancerDonald L Trump, Douglas M Potter, Josephia Muindi, et al.
Cancer Research|August 17, 2006
Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cellsYingyu Ma, Wei-Dong Yu, Rui-Xian Kong, et al.
The Prostate|June 4, 2004
Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathwaySoo Ok Lee, Wei Lou, Candace S Johnson, et al.
Oncology|March 20, 2004
Pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 in normal mice after systemic exposure to effective and safe antitumor dosesJosephia R Muindi, Ruth A Modzelewski, Yibing Peng, et al.
Cancer Chemotherapy and Pharmacology|May 27, 2005
Pharmacokinetics of liquid calcitriol formulation in advanced solid tumor patients: comparison with caplet formulationJosephia R Muindi, Douglas M Potter, Yibing Peng, et al.
The Journal of Biological Chemistry|August 27, 2011
Dexamethasone enhances 1alpha,25-dihydroxyvitamin D3 effects by increasing vitamin D receptor transcriptionAlejandro A Hidalgo, Kristin K Deeb, J Wesley Pike, et al.
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Journal of Traumatic Stress|August 31, 2010
Exposure to traumatic events among treatment-seeking, alcohol-dependent women and men without PTSDCandace S Johnson, Jaimee L Heffner, Thomas J Blom, et al.
Anticancer Research|August 5, 2006
The antitumor efficacy of calcitriol: preclinical studiesCandace S Johnson, Josephia R Muindi, Pamela A Hershberger, et al.
The Prostate|February 11, 2009
Central quadrant procurement of radical prostatectomy specimensCarl Morrison, Richard Cheney, Candace S Johnson, et al.
Anticancer Research|August 5, 2006
Vitamin D compounds: clinical development as cancer therapy and prevention agentsDonald L Trump, Josephia Muindi, Marwan Fakih, et al.
Cancer|April 7, 2006
Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancerDonald L Trump, Douglas M Potter, Josephia Muindi, et al.
Cancer Research|August 17, 2006
Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cellsYingyu Ma, Wei-Dong Yu, Rui-Xian Kong, et al.
The Prostate|June 4, 2004
Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathwaySoo Ok Lee, Wei Lou, Candace S Johnson, et al.
Oncology|March 20, 2004
Pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 in normal mice after systemic exposure to effective and safe antitumor dosesJosephia R Muindi, Ruth A Modzelewski, Yibing Peng, et al.
Cancer Chemotherapy and Pharmacology|May 27, 2005
Pharmacokinetics of liquid calcitriol formulation in advanced solid tumor patients: comparison with caplet formulationJosephia R Muindi, Douglas M Potter, Yibing Peng, et al.
The Journal of Biological Chemistry|August 27, 2011
Dexamethasone enhances 1alpha,25-dihydroxyvitamin D3 effects by increasing vitamin D receptor transcriptionAlejandro A Hidalgo, Kristin K Deeb, J Wesley Pike, et al.
Pageof 11